-
Blueprint Medicines (NASDAQ:BPMC) Downgraded to Sell Rating by StockNews.com
Source: Buzz FX / 04 Mar 2025 23:21:14 America/New_York
Blueprint Medicines (NASDAQ:BPMC) Downgraded to Sell Rating by StockNews.com Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Blueprint Medicines ( NASDAQ:BPMC - Get Free Report ) was downgraded by equities research analy
Read more...